High Drug Prices, A Systemic Threat

All across our health care system, the high prices of specialty drugs pose a systemic threat to sustainability. And we were reminded this week by two new reports that seniors on Medicare and taxpayers are also at significant financial risk from the cost of these new medicines. Continue reading

Comments are closed.

AHIP Embraces Goals of World Hepatitis Day

Noting the occasion, Karen Ignagni, CEO of America’s Health Insurance Plans, commented that, “Health plans play a vital role in increasing awareness and access to the screenings needed to identify patients at risk for this terrible disease. Our success to eradicate Hepatitis C will require all stakeholders to work collaboratively.” Continue reading

Lower Prices and More Transparency — What Consumers Want from Drug Companies But Aren’t Getting

Prices and transparency – two topics that you will never hear drug companies actively talk about. Continue reading